glp-1 and kidney function Unlocking Cardio-Renal Protection: Breakthrough with Receptor Agonists in Acute Disease of Diabetic Patients GLP-1 Receptor Agonists and Diabetic

K.EsmaeiliH.AbachiF.KhialiS.IslamB.KutaM.et al (2017)

This indirect approach circumvents the bioavailability problems associated with oral glutathione supplementation

Factors such as previous eye problems, cardiovascular disease, and use of other medications known to increase NAION risk (like PDE5 inhibitors) should be carefully evaluated before starting GLP-1 therapy

Molecules 27:4139 Soliman NA, Keshk WA, Rizk FH, Ibrahim MA (2019) The possible ameliorative effect of simvastatin versus sulfasalazine on acetic acid induced ulcerative colitis in adult rats

Mice were treated every other day for a total of ten doses, with daily body weight and food intake measurements (schematic of study design Fig